Invivyd is a clinical-stage biopharmaceutical company dedicated to the discovery, development, and commercialization of life-saving antibody-based therapies. By leveraging a proprietary, integrated technology platform, the company focuses on providing long-term protection against serious viral infectious diseases, with a specialized emphasis on supporting immunocompromised populations who are often overlooked by traditional medical solutions.
The company culture is built on the intersection of rapid scientific advancement and a profound sense of purpose. Employees at Invivyd work in a high-growth, mission-driven environment where performance is rewarded with competitive equity and incentive programs, empowering every team member to contribute directly to groundbreaking developments in human health.